Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study ID
- NCT07375992
- Status
- Recruiting
Conditions
- Glioblastoma (GBM)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Music intervention — OTHEREach GBM study participant in Arm A will receive two 30-minute live synchronous virtual music therapy sessions per week for a period of 8 weeks to be curated by a board-certified music therapist. Arm B participants will receive curated playlists of music created by a music therapist. Participants will then listen to the curated music playlists on the participant's own device twice per week. All participants will complete a total of 16 music therapy sessions, scheduled twice per week over 8 weeks. Each session will last approximately 30 minutes.
Study Details
The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.
Key Dates
- First listed
- Jan 29, 2026
- Start date
- May 26, 2026
- Status verified
- Jun 2026
- Primary completion
- May 26, 2028
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 35 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm A- with Music TherapistsArm A of the study will involve individuals who are assigned to receive twice weekly music therapy sessions with a Music Therapist. These live sessions will be conducted virtually via a Johns Hopkins Compliance virtual platform (e.g., Zoom) each session will last 30 minutes. Participants will complete a total of 16 music therapy sessions, and the frequency is 2 sessions per week for 8 weeks. Participants will complete surveys measuring quality of life once each week.
- Experimental: Arm B- without Music TherapistsArm B of the study participants will meet with a music therapist to create a curated playlist. The participant will then listen independently to music therapy sessions twice a week for thirty minutes. Participants will complete a total of 16 music therapy sessions, and the frequency is 2 sessions per week for 8 weeks. Participants will complete surveys measuring quality of life once each week.
Primary Outcome Measure
Success rate of Music Therapy intervention for GBM patients [ Time Frame: 6 months ]
Central Contacts
- Principal Investigator- Matthias Holdhoff, MD, PhD.410-995-8837
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oncology- Broadway | Baltimore | Maryland | 21287 |
Find similar trials in Baltimore, MD
By research site
Related Studies
- Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIPHASE2 · Recruiting · Black Diamond Therapeutics, Inc. · Springdale, Arkansas
- G-CSF After Chemo-radiation in Patients With GlioblastomaPHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)PHASE2 · Recruiting · Diakonos Oncology Corporation · Duarte, California
- Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized TrialPHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts